Ebola vaccine fast-tracked

By on December 24, 2016
Guinée. Fièvre Ebola

A highly vaccine against the deadly Ebola virus could be available by 2018, says the World Health Organization (WHO).
Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection.
The vaccine is now being fast-tracked for regulatory approval.
Manufacturer Merck has made 300,000 doses of the rVSV-ZEBOV vaccine.
Results, published in The Lancet medical journal, show of nearly 6,000 people receiving the vaccine, all were free of the virus 10 days later.
In a group of the same size not vaccinated, 23 later developed Ebola.
It is not known how well the vaccine might work in children since this was not tested in the trial.

About AfricaTimes

Leave a Reply

Your email address will not be published. Required fields are marked *